DORM vs. VC, MTOR, ADNT, ALSN, BWA, GNTX, LEA, MOD, LCII, and DAN
Should you be buying Dorman Products stock or one of its competitors? The main competitors of Dorman Products include Visteon (VC), Meritor (MTOR), Adient (ADNT), Allison Transmission (ALSN), BorgWarner (BWA), Gentex (GNTX), Lear (LEA), Modine Manufacturing (MOD), LCI Industries (LCII), and Dana (DAN). These companies are all part of the "auto/tires/trucks" sector.
Visteon (NASDAQ:VC) and Dorman Products (NASDAQ:DORM) are both mid-cap auto/tires/trucks companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, community ranking, profitability, analyst recommendations, earnings and dividends.
In the previous week, Visteon had 17 more articles in the media than Dorman Products. MarketBeat recorded 24 mentions for Visteon and 7 mentions for Dorman Products. Visteon's average media sentiment score of 0.52 beat Dorman Products' score of 0.38 indicating that Dorman Products is being referred to more favorably in the news media.
Visteon has a beta of 1.46, meaning that its share price is 46% more volatile than the S&P 500. Comparatively, Dorman Products has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500.
Visteon has higher revenue and earnings than Dorman Products. Visteon is trading at a lower price-to-earnings ratio than Dorman Products, indicating that it is currently the more affordable of the two stocks.
99.7% of Visteon shares are held by institutional investors. Comparatively, 84.7% of Dorman Products shares are held by institutional investors. 2.0% of Visteon shares are held by company insiders. Comparatively, 10.0% of Dorman Products shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Dorman Products received 275 more outperform votes than Visteon when rated by MarketBeat users. Likewise, 57.30% of users gave Dorman Products an outperform vote while only 33.10% of users gave Visteon an outperform vote.
Visteon currently has a consensus target price of $134.31, indicating a potential upside of 20.42%. Dorman Products has a consensus target price of $103.00, indicating a potential upside of 2.58%. Given Dorman Products' higher probable upside, research analysts clearly believe Visteon is more favorable than Dorman Products.
Visteon has a net margin of 13.79% compared to Visteon's net margin of 8.10%. Dorman Products' return on equity of 51.69% beat Visteon's return on equity.
Summary
Visteon beats Dorman Products on 11 of the 18 factors compared between the two stocks.
Get Dorman Products News Delivered to You Automatically
Sign up to receive the latest news and ratings for DORM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DORM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Dorman Products Competitors List
Related Companies and Tools
Free DORM Stock Alerts